McMahon et al. [27] showed that high leptin levels greatly increase the risk of subclinical atherosclerosis in SLE and are also associated with an increase in inflammatory biomarkers of atherosclerosis such as HDL, Lp(a), and oxPL/apoB100. Here, APOB is linked to systemic lupus erythematosus.